Skip to content

Low Intensity Shock Wave Therapy in the Rehabilitation Treatment of Erectile Dysfunction After Robotic Radical Prostatectomy.

Low Intensity Shock Wave Therapy in the Rehabilitation Treatment of Erectile Dysfunction After Robotic Radical Prostatectomy: Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06442020
Enrollment
158
Registered
2024-06-04
Start date
2023-09-15
Completion date
2026-09-15
Last updated
2024-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfunction

Brief summary

The study deals with the hypothesis that LiESWT in addition to the administration of PDE5i can improve sexuality rehabilitation with faster recovery of a valid erection and higher IIEF-5 scores in the short and medium-term follow-up.

Detailed description

Prospective randomized controlled trial (RCT) designed to provide high level evidences describing the role of Low-intensity Extracorporeal Shock Wave Therapy LiESWT plus early introduction of PDE5i vs early PDE5i alone on penile rehabilitation of erectile dysfunction ED after treatment of post-Robot-Assisted (RA) Radical Prostatectomy (RP) RARP

Interventions

PROCEDURETadalafil (PDE5i)

Tadalafil at a dose of 5mg/day

Sponsors

Regina Elena Cancer Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged ≤75 yrs; * Low-risk PCa (PSA \<10 ng/mL and GS \<7, ISUP grade 1, and cT1-2a) undergoing nerve sparing RARP; * preoperative IIEF-5 score ≥ 17; * First PSA (45d after surgery) \<0.2 * compliants patients able to follow the study protocol and fill in IIEF-5 scores and EORTC quality of life questionnaires; * patients able to provide a written informed consent for the trial.

Exclusion criteria

* anaesthesiologic contraindications to robotic surgery; * patients submitted to pelvic radiotherapy or androgen deprivation; * patients reporting major postoperative complications (CD≥3); * cardiovascular contraindications to PDE5i medical treatment.

Design outcomes

Primary

MeasureTime frameDescription
Impact of LiESWT3 yearsTo evaluate the impact that the use of low intensity extracorporeal shock waves LiESWT in combination with the early administration of phosphodiesterase 5 inhibitors has on the patient in the process of penile rehabilitation in erectile dysfunction following post-assisted radical prostatectomy robot

Secondary

MeasureTime frameDescription
Assess how many patients reach orgasm3 yearsCompare the rate of patients achieving orgasm. The International Index of Erectile Function short form (IIEF-5) questionnaire is the recognized tool for assessing erectile function both before surgery and during follow-up.
Questionnaires of Quality of life3 yearsCompare health-related quality of life outcomes through a validated self-administered questionnaire preoperatively and at postoperative follow-up assessment.

Countries

Italy

Contacts

Primary ContactGiuseppe Simone, Doctor
giuseppe.simone@ifo.it06-5266.5005
Backup ContactRiccardo Mastroianni, Doctor
riccardo.mastroianni@ifo.it06-5266.5005

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026